Page 464 - TBE_Book_V2_2019

Chapter 14: Prevention

15. Prymula R, Pöllabauer EM, Pavlova BG, et al. 24. Leonova GN, Ternovoi VA, Pavlenko EV,
Antibody persistence after two vaccinations Maistrovskaya OS, Protopopova EV, Loktev
with either FSME-IMMUN® Junior or VB. Evaluation of vaccine Encepur Adult for
ENCEPUR® Children followed by third induction of human neutralizing antibodies
vaccination with FSME-IMMUN® Junior. Hum against recent Far Eastern subtype strains of
Vaccin Immunother. 2012;8:736-42 tick-borne encephalitis virus. Vaccine.
2007;25:895-901.
16. Wittermann C, Petri E, Zent O. Long-term
persistence of tick-borne encephalitis 25. Chiba N, Osada M, Komoro K, Mizutani T,
antibodies in children 5 years after first Kariwa H, Takashima I. Protection against tick-
booster vaccination with Encepur Children. borne encephalitis virus isolated in Japan by
Vaccine. 2009;27:1585-8. active and passive immunization. Vaccine.
1999;17:1532-9
17. Zent O, Bröker M. Tick-borne encephalitis
vaccines: past and present. Expert Rev 26. Krasilnikov I, Mischenko IA, Sharova OI,
Vaccines. 2005;4:747-55. Vorob’eva M. Development of technology of
tick-borne encephalitis vaccine (strain 205). Int
18. Zent O, Beran J, Jilg W, Mach T, Banzhoff A. J Med Microbiol. 2002;291:173.
Clinical evaluation of a polygeline-free tick-
borne encephalitis vaccine for adolescents 27. Gorbunov MA, Pavlova LI, Vorob’eva MS,
and adults. Vaccine. 2003;21:738-41. Raschepkina MN, Stronin OB. Results of
clinical evaluation of EncoVir vaccine
19. Zent O, Jilg W, Plentz A, et al. Kinetics of the against tick-borne encephalitis. Epidem
immune response after primary and booster Vaccinoprophil. 2002;5:49.
immunization against tick-borne encephalitis
(TBE) in adults using the rapid immunization 28. Krasilnikov IV, Mischenko IA, Sharova OI, et
schedule. Vaccine. 2003;21:4655-60. al. Vaccine “EnceVir”: development and
implementation in practical use.
20. Zent O, Hennig R, Banzhoff A, Bröker M. Biopreparations. 2004;2:21-4.
Protection against tick-borne encephalitis with 29. Pavlova LI, Stavitskaya IV, Gorbunov MA, al
a new vaccine formulation free of protein- e. Immunizations of children and
derived stabilizers. J Travel Med. 2005;12:85- adolescents with concentrated purified
93.
vaccines against TBE. Biopreparations.
2003;1:24-8.
21. Schoendorf I, Ternak G, Oroszlàn G, Nicolay
U, Banzhoff A, Zent O. Tick-borne encephalitis 30. Stavitskaya IV, Shkuratova OV, Pavlova LI,
(TBE) vaccination in children: advantage of Shutova NA, Sharova OI. Immunological
the rapid immunization schedule (i.e., days 0, effectiveness of EnceVir in children.
7, 21). Hum Vaccin. 2007;3:42-7.
Biopreparations. 2004;2:34–6.
22. Zent O, Banzhoff A, Hilbert AK, Meriste S, 31. Romanenko VV, Esiunina MS, Kiliachina
Sluzewski W, Wittermann C. Safety, AS. [Experience in implementing the mass
immunogenicity and tolerability of a new immunization program against tick-borne
pediatric tick-borne encephalitis (TBE) encephalitis in the Sverdlovsk Region].
vaccine, free of protein-derived stabilizer. Vopr Virusol. 2007;52:22-5.
Vaccine. 2003;21:3584-92.
32. Borodina TN, Evtoushok GA, Tevelenok
23. Wittermann C, Schöndorf I, Gniel D. OG, Opeikina NN. Epidemiological
Antibody response following effectiveness of vaccination against TBE
administration of two paediatric tick- in Krasnoyarsk region. Biopreparations.
borne encephalitis vaccines using two 2004;2:30-1.
different vaccination schedules.
Vaccine. 2009;27:1661-6.
466
459